axitinib
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of advanced renal cell carcinoma in cases where a previous course of systemic therapy has not been effective.
Form: tablets, film-coated
Active substance Dosage axitinib 1 mg ATC: L01XE17
Manufacturer: Shilpa Medica Limited
-
The drug is prescribed for the treatment of advanced renal cell carcinoma if a previous course of systemic therapy has not been effective.
Form: tablets, film-coated
Active substance Dosage axitinib 5 mg ATC: L01XE17
Manufacturer: Shilpa Medica Limited
-
The drug is intended for the treatment of advanced renal cell carcinoma (kidney cancer) in cases where a previous course of systemic therapy has not been effective.
Form: tablets, film-coated
Active substance Dosage axitinib 1 mg ATC: L01EK01
Manufacturer: Synthon Hispania, S.L.
-
The drug is intended for the treatment of advanced renal cell carcinoma (kidney cancer) in cases where a previous course of systemic therapy has not been effective.
Form: tablets, film-coated
Active substance Dosage axitinib 5 mg ATC: L01EK01
Manufacturer: Synthon Hispania, S.L.
-
It is used for the treatment of advanced renal cell carcinoma in cases where a previous course of systemic therapy has not been effective.
Form: tablets, film-coated
Active substance Dosage axitinib 1 mg ATC: L01XE17
-
It is used to treat advanced renal cell carcinoma if a previous course of systemic therapy has not been effective.
Form: tablets, film-coated
Active substance Dosage axitinib 5 mg ATC: L01XE17